President’s Column January 2025

President’s Column January 2025

Dear IABS Colleagues, Stakeholders, Supporters, and Collaborators, Welcome to the new year! I am pleased to report that the International Alliance for Biological Standardization (IABS) Board of Directors and the General Assembly had very successful meetings in...
President’s Column January 2025

President’s Column September 2024

Dear IABS members and stakeholders, Our journal, Biologicals, reached an important milestone in 2023; it’s 50th Anniversary.  If you have not read Volume 85, February 2024, I suggest checking out the first article entitled Fifty Years of Advancing Biologicals and...
Actors4Health

Actors4Health

IABS’ vision is « health solutions for everyone everywhere”. IABS achieves this through open exchanges between all stakeholders in the field of biologicals (vaccines, biotherapeutics, cell and gene therapy). The ultimate goal is to increase access to so needed...
President’s Column January 2025

President’s Column April 2024

Dear IABS Colleagues, Stakeholders, Supporters and Collaborators,  2024, IABS is prepared for an eventful year, driven by the dedication or our volunteers who have confirmed meetings on crucial topics like Next Generation Sequencing, Vaccination Strategies for High...
In Memoriam

In Memoriam

David A. Espeseth   David A. Espeseth, 84, of Perkasie, Pennsylvania, USA passed away on Saturday, February 3, 2024. David was an IABS Leader and served many roles within the organization. He attended the University of Minnesota, where he earned Bachelor of...
IABS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.